On March 5, Dechert is proud to host 2025 Life Sciences Day, an interdisciplinary program designed for in-house counsel, chief officers, and strategic investors. This dynamic half-day event offers a fantastic opportunity to network with industry leaders and delve into the latest trends and insights shaping the life sciences sector.
The event will feature expert-led panels and discussions on current challenges and opportunities in biotech and pharma, with panelists from Bristol Myers Squibb, Context Therapeutics, Fortress Investment Group, GlaxoSmithKline, Johnson & Johnson, Morgan Stanley, and Regeneron Pharmaceuticals. Click here to register.
The topics we’ll cover include:
- Trends in Competition Challenges to Drug Pricing
- Capital Raising and Asset Monetization Strategies for Life Sciences Companies
- Drug Discovery, Funding, Licensing and Litigating Intellectual Property Disputes
- Key Appeals Shaping Life Sciences Litigation and Regulation
In addition, we’re excited to host a fireside chat with Patrick M. Oates, Ph.D., Senior Vice President of Strategic Planning & Business Development, EMSCO Scientific Enterprises, Inc. Dr. Oates is the Advisory Board Chair of PHL Life Sciences, a division of the Philadelphia Convention and Visitors Bureau (PHLCVB). PHL Life Sciences aims to enhance Philadelphia’s reputation as a premier hub in the life sciences industry.
Event Details:
Location: Dechert LLP | PHL, Cira Centre, 2929 Arch Street, Philadelphia, PA 19104
Date: Wednesday, March 5, 2025
12:00 p.m. – Registration and Lunch
12:25 p.m. – Program
4:30 p.m. – Networking Reception
Join us for a day of innovation and inspiration. We look forward to seeing you there!
CLE Information:
Applications for accreditation of this program for Continuing Legal Education in Massachusetts, New Jersey, New York, and Pennsylvania are currently pending.